These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8063069)

  • 1. Prevention of embolism in elective cardioversion of atrial fibrillation.
    Mancini GB
    G Ital Cardiol; 1994 Mar; 24(3):331-40. PubMed ID: 8063069
    [No Abstract]   [Full Text] [Related]  

  • 2. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation.
    Josephson RA
    Circulation; 1994 Dec; 90(6):3122. PubMed ID: 7994866
    [No Abstract]   [Full Text] [Related]  

  • 3. Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion.
    Ezekowitz MD; Cappato R; Klein AL; Camm AJ; Ma CS; Le Heuzey JY; Talajic M; Scanavacca MI; Vardas PE; Kirchhof P; Hohnloser SH; Hemmrich M; Lanius V; Meng IL; Wildgoose P; van Eickels M
    Am Heart J; 2014 May; 167(5):646-52. PubMed ID: 24766973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactic administration of anticoagulant therapy in electric cardioversion for atrial fibrillation or atrial flutter].
    Jirmár R; Gregor P
    Cor Vasa; 1993; 35(3):K81-2. PubMed ID: 8348810
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atrial fibrillation].
    Kappenberger L; Fromer M
    Praxis (Bern 1994); 1996 Apr; 85(18):600-3. PubMed ID: 8701164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transesophageal echocardiography may not lessen stroke rate from cardioversion.
    Vine DL
    Kans Med; 1994 Apr; 95(4):100, 96. PubMed ID: 8041051
    [No Abstract]   [Full Text] [Related]  

  • 7. [Atrial fibrillation--the value of transesophageal echocardiography].
    Erbel R; Schön F; Leischik R; von Birgelen C; Zeppelini R
    Z Kardiol; 1994; 83 Suppl 5():41-7. PubMed ID: 7846944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problem of definition of embolic risk in the procedure of elective cardioversion of atrial fibrillation].
    Lanzarini L
    Recenti Prog Med; 1989 Jan; 80(1):45. PubMed ID: 2711013
    [No Abstract]   [Full Text] [Related]  

  • 9. Transesophageal echocardiography before cardioversion.
    Grimm RA; Black IW; Klein AL
    N Engl J Med; 1993 Aug; 329(8):577-8. PubMed ID: 8336760
    [No Abstract]   [Full Text] [Related]  

  • 10. Further evidence in support of anticoagulant therapy before elective cardioversion of atrial fibrillation.
    DiMarco JP
    J Am Coll Cardiol; 1992 Mar; 19(4):856-7. PubMed ID: 1545082
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation.
    Marchant BG; Timmis AD
    Br J Hosp Med; 1993 Feb 3-16; 49(3):186-90. PubMed ID: 8439785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use and clinical implications of anticoagulation maintenance after a successful cardioversion].
    Alegret JM; Viñolas X; Villacastín J; Martínez JG; Pachón N; Crespo F;
    Med Clin (Barc); 2011 Jun; 137(1):14-6. PubMed ID: 21056435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of transesophageal echocardiography in cardioversion for atrial fibrillation].
    Galzerano D; Giasi M; Tuccillo B
    G Ital Cardiol; 1995 Dec; 25(12):1681-2. PubMed ID: 8707020
    [No Abstract]   [Full Text] [Related]  

  • 14. Time to cardioversion for acute atrial fibrillation and thromboembolic complications.
    Nuotio I; Hartikainen JE; Grönberg T; Biancari F; Airaksinen KE
    JAMA; 2014 Aug; 312(6):647-9. PubMed ID: 25117135
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the prophylactic use of synthetic anticoagulants before cardioversion in atrial fibrillation].
    Fiori W; Civai O
    Atti Accad Fisiocrit Siena Med Fis; 1966; 15(1):67-76. PubMed ID: 6001460
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of direct current cardioversions for atrial arrhythmia.
    Johnston SD; Trouton TG; Wilson C
    Ulster Med J; 1998 May; 67(1):19-24. PubMed ID: 9652194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
    Kinch JW; Davidoff R
    Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of transoesophageal echocardiography before DC cardioversion in patients with atrial fibrillation: assessment of embolic risk.
    Schnittger I
    Br Heart J; 1995 Apr; 73(4):306-9. PubMed ID: 7756062
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulation for cardioversion of atrial fibrillation.
    Weinberg DM; Mancini J
    Am J Cardiol; 1989 Mar; 63(11):745-6. PubMed ID: 2923062
    [No Abstract]   [Full Text] [Related]  

  • 20. [Does the absence of thrombi in the transesophageal echocardiogram justify cardioversion without anticoagulant prophylaxis in patients with atrial fibrillation?].
    Scardi S
    G Ital Cardiol; 1994 Dec; 24(12):1626-9. PubMed ID: 7883137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.